ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataShowing 20 of 12247 recruiting trials
Effectiveness of Pucotenlimab Combined With Standard Chemotherapy Regimen
RecruitingNCT06466889 ↗
Mastocytosis Registry (of Zurich)
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
👨⚕️ Vice President Global Head of Clinical Development and Safety, X4 Pharmaceuticals📍 109 sites📅 Started Jun 2024View details ↗
Inspiratory Muscle Training in Children With Beta Thalasemia
👨⚕️ hagar el-hadidy, lecturer, Faculty of Physical Therapy, Ahram Canadian University (ACU), Giza, Egypt📍 1 site📅 Started Jun 2024View details ↗
A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)
Study of CT071 Injection in High Risk Newly Diagnosed Multiple Myeloma
Is There Effect of Adding Honey Intake to Free Walking in Metabolic Syndrome Children
👨⚕️ hagar el-hadidy, lecturer, Faculty of Physical Therapy, Ahram Canadian University (ACU), Giza, Egypt📍 1 site📅 Started Jun 2024View details ↗
Radioembolization With Tremelimumab and Durvalumab for Locally Advanced Unresectable or Oligo-Metastatic Intrahepatic Cholangiocarcinoma
Efficacy and Safety of Adebrelimab Combined With Chemoradiotherapy in Patients With Unresectable Locally Advanced or Postoperative Recurrent Esophageal Squamous Cell Carcinoma
MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.
Utidelone Capsule Plus Capecitabine (CAP) for Metastatic Breast Cancer
Vasodilator and Exercise Study for DMD (VASO-REx)
👨⚕️ Tanja Taivassalo, Ph.D., University of Florida, College of Medicine, Department of Physiology and Aging📍 1 site📅 Started Jun 2024View details ↗
RecruitingNCT06455709 ↗
Markers of Favorable Response to Complement Inhibitors Therapy
👨⚕️ Raffaele Iorio, Fondazione Policlinico Universitario A. Gemelli, IRCCS📍 1 site📅 Started Jun 2024View details ↗
Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC
Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Disease
👨⚕️ Arian Pano, MD, MPH, Clinical Development and Progam Lead, uniQure Biopharma, B.V.📍 8 sites📅 Started Jun 2024View details ↗
RecruitingNCT06410976 ↗
Prospective Clinical Assessment Study in Children With Hypochondroplasia
Study of NXC-201 CAR-T in Patients With Light Chain (AL) Amyloidosis
Evaluating a Community-Based Behaviour Change Communication Model to Prevent Cholangiocarcinoma in Khon Kaen, Thailand
RecruitingNCT06553976 ↗
Spastic Paraplegia - Centers of Excellence Research Network
RecruitingNCT06472557 ↗
Spinocerebellar Ataxia Type 27B Natural History Study (SCA27B-NHS)
👨⚕️ Matthis Synofzik, Prof. Dr., University Hospital Tübingen📍 4 sites📅 Started Jun 2024View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →